Healthcare >> CEO Interviews >> August 28, 2014
Paul R. Edick has served as Durata Therapeutics, Inc.’s Chief Executive Officer and as a member of our board of directors since July 2010. From 2008 to 2010, Mr. Edick served as Chief Executive Officer of GANIC Pharmaceuticals, Inc. From 2006 to 2008, Mr. Edick served as Chief Executive Officer of MedPointe Inc. until its acquisition by Meda AB. Mr. Edick also serves as a member of the board of directors of NewLink Genetics Corporation and Circassia Ltd. From 2008 to 2011, Mr. Edick served as Chairman of the board of directors of LifeCycle Pharma A/S. Mr. Edick holds a B.A. in psychology from Hamilton College in Clinton, New York. Profile
Mr. Edick: Durata Therapeutics started as a development organization four years ago with one asset,
